Page last updated: 2024-08-24

cidofovir anhydrous and Astrocytoma, Grade IV

cidofovir anhydrous has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobbs, CS; Fiallos, E; Hadaczek, P; James, CD; Matlaf, L; Ozawa, T; Singer, E; Soroceanu, L; Yoshida, Y1

Other Studies

1 other study(ies) available for cidofovir anhydrous and Astrocytoma, Grade IV

ArticleYear
Cidofovir: a novel antitumor agent for glioblastoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-01, Volume: 19, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cidofovir; Cytosine; DNA Breaks, Double-Stranded; DNA Replication; Female; Glioblastoma; Humans; Mice; Mice, Nude; Organophosphonates; Spheroids, Cellular; Tumor Burden; Xenograft Model Antitumor Assays

2013